Targeted protein degradation dismantles undruggable targets to reverse immune evasion and therapy resistance in cancer
Targeted protein degradation (TPD) harnesses endogenous proteolytic machineries—the ubiquitin–proteasome system and lysosomal pathways—to selectively eliminate disease-causing proteins that are refractory to conventional inhibition. In cancer immunothe…